10 completed, 9 unknown, 5 not yet recruiting, 4 recruiting. 8 Phase 2, 6 Not applicable, 4 Phase 1, 4 Phase 3, 3 Phase 4.
Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin D in Diabetic Neuropathy Vitamin D - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 150 | 2026-10-01 | 2026-09-08 |
| Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy Human umbilical cord mesenchymal stem cell injection - Diabetic Nephropathy Type 2 | Phase 1 / Phase 2 | Not yet recruiting | The First People's Hospital of Changzhou | 49 | 2026-09-01 | 2026-08-18 |
| Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial Umbilical Cord Mesenchymal Stem Cells - Diabetic Nephropathy Type 2 | Phase 1 / Phase 2 | Recruiting | PT. Prodia Stem Cell Indonesia | 10 | 2026-07-01 | 2026-02-09 |
| Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence Jiajian Yishen Xiaozheng Qufeng Granules - Diabetic Nephropathy Type 2, Chronic Renal Failure/ Kidney Disease | Not applicable | Not yet recruiting | Jiazhen Yin | 198 | 2026-03-12 | 2026-03-10 |
| Relationship of Serum Zinc Level With Severity of Diabetic Nephropathy Diabetic Nephropathy Type 2 | Not yet recruiting | Assiut University | 92 | 2025-12-01 | 2024-11-15 | |
| Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes Polygenic Risk Score - Diabetes Mellitus, Type 2, Cardiovascular Diseases | Not applicable | Recruiting | Optithera | 2714 | 2024-08-23 | 2024-09-19 |
| Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status clinical periodontal measurements, serum samples, saliva samples - Diabetic Nephropathy Type 2, Type 2 Diabetes | Completed | Pamukkale University | 126 | 2024-06-10 | 2026-03-27 | |
| Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients Experimental group 1 :Ball training, Experimental group 2 :Frenkel Exercises, Control Group - Diabetic Nephropathy Type 2 | Not applicable | Completed | Dr. Sobia Hasan | 90 | 2024-05-05 | 2024-12-31 |
| Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study. Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2 | Not applicable | Unknown | Yan Bi | 106 | 2024-02-20 | 2024-01-24 |
| Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy Acetylsalicylic Acid, Placebo - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 355 | 2024-01-01 | 2023-10-05 |
| Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Empagliflozin 25 MG, Enalapril Maleate 20 mg - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Unknown | Omar Tarek Elfarargi | 212 | 2023-03-01 | 2022-05-13 |
| Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy Diabetic Nephropathy Type 2, Diabetic Kidney Disease | Recruiting | Chinese PLA General Hospital | 2000 | 2022-08-01 | 2023-06-05 | |
| Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients Dapagliflozin - Diabetic Nephropathy Type 2 | Phase 4 | Completed | Mohammed Mahmood Mohammed | 40 | 2022-05-01 | 2024-03-22 |
| Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus (T2DM) | Completed | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | 556 | 2022-04-18 | 2026-08-12 | |
| Investigational and Comparative Study in the Management of Diabetic Nephropathy Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet - Diabetic Nephropathy Type 2 | Phase 3 | Completed | Tanta University | 90 | 2022-02-01 | 2024-05-14 |
| Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy Enzyme linked immunosorbent assay - Diabetic Nephropathy Type 2 | Unknown | Zheng Guo | 180 | 2021-08-01 | 2021-07-15 | |
| Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. Diabetic Nephropathy Type 2, Biomarker | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1000 | 2021-05-01 | 2021-07-20 | |
| Atrasentan in Patients With Proteinuric Glomerular Diseases Atrasentan - IgA Nephropathy, Focal Segmental Glomerulosclerosis | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 103 | 2021-03-15 | 2026-06-01 |
| Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy Sleep Apnea, Diabetic Nephropathy Type 2 | Completed | University of Aarhus | 74 | 2020-10-01 | 2022-02-07 | |
| Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose, Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose - Diabetic Kidney Disease, Diabetic Nephropathies | Phase 1 | Terminated | Mayo Clinic | 2 | 2019-10-23 | 2025-08-17 |
Showing 20 of 31. Sign in to see all of them.
Diabetic Nephropathies (9) · Diabetes Mellitus, Type 2 (7) · Kidney Diseases (3) · Renal Insufficiency, Chronic (3) · Albuminuria (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Neuropathies (1) · Disease (1) · Genetic Risk Score (1) · Gingivitis (1) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1)
Endocrine System Diseases (13) · Diabetes Mellitus (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Male Urogenital Diseases (12) · Urogenital Diseases (12) · Urologic Diseases (12) · Diabetes Complications (10) · Kidney Diseases (9) · Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Glucose Metabolism Disorders (7) · Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (5) · Disease Attributes (4)
Enalapril (2) · empagliflozin (2) · Asian ginseng (1) · Aspirin (1) · Atrasentan (1) · Clinical Laboratory Techniques (1) · Continuous Glucose Monitoring (1) · Control Groups (1) · Dorzagliatin (1) · Eplerenone (1) · Gestyl (1) · Gliclazide (1) · Linagliptin (1) · Lisinopril (1) · Losartan (1)
Assiut University (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Shanghai University of Traditional Chinese Medicine (2) · Tanta University (2) · Beni-Suef University (1) · Centro Universitario de Ciencias de la Salud, Mexico (1) · Chang Gung Memorial Hospital (1) · Chinese PLA General Hospital (1) · Copenhagen University Hospital, Rigshospitalet (1) · Dr. Sobia Hasan (1) · James A. Tumlin, MD (1) · Jiazhen Yin (1) · Leiden University Medical Center (1) · Mayo Clinic (1) · Mohammed Mahmood Mohammed (1)
China (7) · Denmark (3) · United States (3) · Egypt (2) · Italy (2) · Australia (1) · Canada (1) · Indonesia (1) · Iraq (1) · Mexico (1) · Netherlands (1) · Pakistan (1) · South Korea (1) · Spain (1) · Taiwan (1)
Yueyi Deng, PhD (2) · Aftab Ahmed Mirza Baig, PhD (1) · Chao Zheng, MD,PhD (1) · Jakob T. Nyvad, MD (1) · Juan Huang, Doctor (1) · LaTonya J Hickson, MD (1) · Mostafa O El Mokadem, M.D. (1) · Niels H. Buus, MD PhD DMSc (1) · Omar T Elfarargi (1) · Pavel Hamet, MD, PhD (1) · Rong Yu, Doctor (1) · Sebastian Nielsen, MD student (1) · Sobia Hasan, PhD* (1) · Ton J. Rabelink, Prof. (1)
PMID 32848436, PMID 33131308, PMID 34533892, PMID 34788550, PMID 34940288, PMID 37254256, PMID 38600065, PMID 38915115, PMID 39228893, PMID 39899371, PMID 40938675, PMID 41141513, PMID 41442197